BCM
IVVD icon

Bronte Capital Management’s Invivyd IVVD Stock Holding History

Bronte Capital Management’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,012
Closed -$14.3K – 60
2026
Q1 		$14.3K Hold
11,012
– – ﹤0.01% 51
2025
Q4 		$27.2K Buy
+11,012
New +$22.9K ﹤0.01% 38

Other funds holding IVVD

JT
Jupiter Topco New York $245B AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Bronte Capital Management's IVVD Position: Q2 2026 in Review

Bronte Capital Management sold out of Invivyd (IVVD) in Q2 2026, closing a stake of 11,012 shares — an estimated $14.3K sold.

Bronte Capital Management first reported a position in IVVD in Q4 2025 and held it in 2 quarters. The position peaked at $27.2K in Q4 2025. 125 funds tracked by Wall St. Rank hold IVVD as of Q2 2026.

  • Bronte Capital Management reported no remaining Invivyd position as of Q2 2026 after selling out during the quarter.
  • Bronte Capital Management sold 11,012 Invivyd shares in Q2 2026, an estimated $14.3K.
  • Bronte Capital Management first reported a position in Invivyd in Q4 2025 and held it in 2 quarters.
  • Bronte Capital Management's Invivyd position peaked at $27.2K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Invivyd as of Q2 2026.

Based on Bronte Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.